Edge Therapeutics (EDGE) Tops Q4 EPS by 2c

Edge Therapeutics (NASDAQ: EDGE) reported Q4 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Edge Therapeutics (EDGE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c